Craig-Hallum initiated coverage of Sophia Genetics (SOPH) with a Buy rating and $11 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOPH:
- SOPHiA GENETICS Q3 2024 Financial Highlights
- Sophia Genetics CFO Ross Muken promoted to president, George Cardoza to succeed
- SOPHiA GENETICS Faces Financial Challenges Amid Losses
- SOPHiA GENETICS Announces Key Leadership Appointments
- Sophia Genetics backs FY24 revenue view $65M-$67M, consensus $65.66M